Transgenic Group (2342) · InitiativeRestated
Expanding order-taking capacity by strengthening staffing in both manufacturing and sales
First written in FY2018-Q1. 1 of 2 entries say "Restated". Latest entry: FY2018-Q2.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Expansion of order-taking capacity through reinforcement of manufacturing and sales personnelA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2018-Q2RestatedAnnual report
「In terms of costs, we made upfront investments, including strengthening staffing in both manufacturing and sales, with the aim of expanding order capacity.」
The company continues to describe upfront investments, including strengthening staffing in manufacturing and sales, to expand order capacity in the genomics business. - FY2018-Q1First statedAnnual report
「In terms of costs, we made upfront investments, including strengthening staffing in both manufacturing and sales, with the aim of expanding order capacity.」
As a new specific measure to expand order capacity in the genomics business, the company describes upfront investments, including strengthening staffing in both manufacturing and sales.